X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

GALT

Closed

Galectin Therapeutics Inc

2.23
+0.12 (+5.69%)
Last Update: 01 Jul 2025 23:19:00
Yesterday: 2.11
Day's Range: 2.1 - 2.27
Send
When Written:
 
2.0501
Galectin Therapeutics Inc. is a biotechnology company that focuses on the development of therapies for fibrotic diseases and cancer. The company's lead product candidate is GR-MD-02, a galectin-3 inhibitor, which is being developed for the treatment of liver fibrosis and fatty liver disease. The company is also developing other galectin inhibitors for the treatment of cancer and other fibrotic diseases. Galectin Therapeutics Inc. was founded in 2000 and is headquartered in Norcross, Georgia.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X